SUBSCRIBE
SUBSCRIBE
News   Drug Development

Antipsychotic Drugs, Including Eli Lilly and Company’s Zyprexa And Johnson & Johnson’s Risperdal, Triple Risk of Death for Dementia Patients

May 27, 2008 | 
1 min read

Bloomberg -- People with dementia more than tripled their risk of death or hospitalization within a month of taking antipsychotic drugs to silence their agitation, according to a study.

Clinical research Postmarket research
Johnson & Johnson Family of Companies Eli Lilly and Company
MORE ON THIS TOPIC
Brain with pills, Alzheimer awareness day, dementia diagnosis, Parkinson disease, memory loss disorder, damaged mind
Huntington’s disease
PTC Nosedives Despite Claiming Phase II Win for Huntington’s Hopeful
May 5, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Vaccine and syringe injection. Doctor hand with syringe. Vaccination of people for prevention, immunization and treatment from virus infection. Medicine, flu shot, test with needle. Vector
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
May 1, 2025
 · 
3 min read
 · 
Heather McKenzie
Conceptual business illustration of upcoming business problem metaphor with falling domino and businessman silhouette. Minimalistic vector eps 10 illustration
Multiple sclerosis
Immunic Talks Up Disability Gains as Phase II MS Therapy Fails on Primary Endpoint
May 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Chicago, Illinois, USA on Lake Michigan at dawn.
Cancer
AACR 2025 Tracker: Merck, GSK, Roche and More Present Key Data
April 30, 2025
 · 
8 min read
 · 
BioSpace Editorial Staff